Search Results - "van Aalst, Mariëlle"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Incidence of invasive pneumococcal disease in immunocompromised patients: A systematic review and meta-analysis by van Aalst, Mariëlle, Lötsch, Felix, Spijker, René, van der Meer, Jan T.M., Langendam, Miranda W., Goorhuis, Abraham, Grobusch, Martin P., de Bree, Godelieve J.

    Published in Travel medicine and infectious disease (01-07-2018)
    “…Invasive pneumococcal disease (IPD) is associated with high morbidity and mortality, with immunocompromised patients (ICPs) at particular risk. Therefore,…”
    Get full text
    Journal Article
  2. 2

    The impact of menopause on work ability in women with severe menopausal symptoms by Geukes, Marije, van Aalst, Mariëlle P, Robroek, Suzan J.W, Laven, Joop S.E, Oosterhof, Henk

    Published in Maturitas (01-08-2016)
    “…Highlights • In today's society, many women will be working throughout their menopausal transition. • Menopause may cause a wide variety of physical symptoms…”
    Get full text
    Journal Article
  3. 3

    Long-term pneumococcal vaccine immunogenicity following allogeneic hematopoietic stem cell transplantation by Langedijk, Annefleur C., van Aalst, Mariëlle, Meek, Bob, van Leeuwen, Ester M.M., Zeerleder, Sacha, Meijer, Ellen, Hazenberg, Mette D., Grobusch, Martin P., Goorhuis, Abraham

    Published in Vaccine (14-01-2019)
    “…•We recommend a new pneumococcal vaccination scheme after allo-HSCT.•This scheme combines the benefits of early (≤6 months) and late (>1 year)…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Travel-related health problems in the immunocompromised traveller: An exploratory study by van Aalst, Mariëlle, van Ruissen, Marella C.E., Verhoeven, Roos, de Bree, Godelieve J., Goorhuis, Abraham, Grobusch, Martin P.

    Published in Travel medicine and infectious disease (01-09-2018)
    “…Immunocompromised travellers (ICTs) are at increased risk of travel-related health problems. Therefore, they are advised to attend specialised pre-travel…”
    Get full text
    Journal Article
  7. 7

    Pre-travel care for immunocompromised and chronically ill travellers: A retrospective study by van Aalst, Mariëlle, Verhoeven, Roos, Omar, Freshta, Stijnis, Cornelis, van Vugt, Michèle, de Bree, Godelieve J., Goorhuis, Abraham, Grobusch, Martin P.

    Published in Travel medicine and infectious disease (01-09-2017)
    “…Immunocompromised and chronically ill travellers (ICCITs) are susceptible to travel related diseases. In ICCITs, pre-travel care regarding vaccinations and…”
    Get full text
    Journal Article
  8. 8

    Long-term sequelae of chikungunya virus disease: A systematic review by van Aalst, Mariëlle, Nelen, Charlotte Marieke, Goorhuis, Abraham, Stijnis, Cornelis, Grobusch, Martin Peter

    “…Abstract Background The acute phase of chikungunya is well documented; less so are its long-term effects. This systematic literature review provides an…”
    Get full text
    Journal Article
  9. 9

    The effect of immunosuppressive agents on immunogenicity of pneumococcal vaccination: A systematic review and meta-analysis by van Aalst, Mariëlle, Langedijk, Annefleur C., Spijker, René, de Bree, Godelieve J., Grobusch, Martin P., Goorhuis, Abraham

    Published in Vaccine (18-09-2018)
    “…•Immunosuppressive agents mitigate the immune response to pneumococcal vaccination.•Anti-TNFα is associated with a better response than DMARDS or combination…”
    Get full text
    Journal Article
  10. 10

    Evaluation of a workplace educational intervention on menopause: A quasi-experimental study by Geukes, Marije, Anema, Johannes R., Vermeer, Marloes, van Aalst, Mariëlle P., Oosterhof, Henk

    Published in Maturitas (01-08-2023)
    “…•There is a paucity of studies on workplace interventions related to menopause.•An educational workplace intervention on menopause increases women's…”
    Get full text
    Journal Article
  11. 11

    Attitude, confidence and social norm of Dutch occupational physicians regarding menopause in a work context by Geukes, Marije, Oosterhof, Henk, van Aalst, Mariëlle P., Anema, Johannes R.

    Published in Maturitas (01-09-2020)
    “…•Most occupational physicians do recognize a role for menopause in presenteeism and sickness absence.•Generally, Dutch occupational physicians have a positive…”
    Get full text
    Journal Article
  12. 12

    Improvement of menopausal symptoms and the impact on work ability: A retrospective cohort pilot study by Geukes, Marije, Anema, Johannes R., van Aalst, Mariëlle P., de Menezes, Renee X., Oosterhof, Henk

    Published in Maturitas (01-02-2019)
    “…•Both menopausal symptoms and work ability improve following treatment.•Depressive symptoms are mainly responsible for improvement in work ability.•Improvement…”
    Get full text
    Journal Article
  13. 13

    The impact of menopausal symptoms on work ability by Geukes, Marije, van Aalst, Mariëlle P., Nauta, Mary C.E., Oosterhof, Henk

    Published in Menopause (New York, N.Y.) (01-03-2012)
    “…OBJECTIVEMenopause is an important life event that may have a negative influence on quality of life. Work ability, a concept widely used in occupational…”
    Get full text
    Journal Article
  14. 14

    Yellow fever vaccination – Once in a lifetime? by Grobusch, Martin P, van Aalst, Mariëlle, Goorhuis, Abraham

    Published in Travel medicine and infectious disease (01-01-2017)
    “…An additional and difficult problem in establishing the duration of protective immunity in various patient groups and at various vaccine doses is the lack of…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Title: Incidence of invasive pneumococcal disease in immunocompromised patients: A systematic review and meta-analysis by van Aalst, Mariëlle, Lötsch, Felix, Spijker, René, van der Meer, Jan T M, Langendam, Miranda W, Goorhuis, Abraham, Grobusch, Martin P, de Bree, Godelieve J

    Published in Travel medicine and infectious disease (31-05-2018)
    “…Invasive pneumococcal disease (IPD) is associated with high morbidity and mortality, with immunocompromised patients (ICPs) at particular risk. Therefore,…”
    Get full text
    Journal Article